Research Calls I
-
Upgrades:
- AT&T (T) upgraded to Outperform from Neutral at Exane BNP Paribas; tgt $28.50
- Casey's General (CASY) upgraded to Buy from Hold at Gordon Haskett
- Cisco (CSCO) upgraded to Buy from Neutral at Rosenblatt; tgt raised to $80
- Coca-Cola (KO) upgraded to Buy from Hold at DZ Bank; tgt $75
- CVS Health (CVS) upgraded to Outperform from Market Perform at Leerink Partners; tgt raised to $75
- Genmab (GMAB) upgraded to Outperform from Market Perform at Leerink Partners; tgt $27
- Gilead Sciences (GILD) upgraded to Buy from Hold at DZ Bank; tgt $108
- Manhattan Assoc (MANH) upgraded to Outperform from Mkt Perform at William Blair
- STMicroelectronics (STM) upgraded to Equal-Weight from Underweight at Morgan Stanley
-
Downgrades:
- 10x Genomics (TXG) downgraded to Market Perform from Outperform at Leerink Partners; tgt lowered to $12
- Aspen Aerogels (ASPN) downgraded to Neutral from Buy at Seaport Research Partners
- Fluence (FLNC) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $8
- General Dynamics (GD) downgraded to Neutral from Buy at BTIG Research
- Kraft Heinz (KHC) double downgraded to Underperform from Buy at BofA Securities; tgt lowered to $30
- Kraft Heinz (KHC) downgraded to Neutral from Buy at Citigroup; tgt lowered to $28
- Macy's (M) downgraded to Accumulate from Buy at Gordon Haskett
- Olin (OLN) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $33
- The Trade Desk (TTD) downgraded to In-line from Outperform at Evercore ISI; tgt lowered to $90
-
Others:
- Amer Sports (AS) re-initiated with an Outperform at Bernstein; tgt $38
- Fortis (FTS) initiated with a Hold at Jefferies
- GE Vernova (GEV) initiated with an Outperform at Robert W. Baird; tgt $448
- GH Research PLC (GHRS) initiated with an Overweight at Cantor Fitzgerald; tgt $14
- Lemaitre Vascular (LMAT) initiated with an Equal Weight at Wells Fargo; tgt $95